Cipla Ltd (CIPLA)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

1,12,584.7

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 26,615 full-time employees. The firm operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The firm's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The firm's geographical segments include India, the United States, South Africa, and Rest of the World. The firm has its network of manufacturing, trading and other incidental operations in India and International markets. The firm has approximately 47 manufacturing sites.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 1,330.9

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

27.72

52-week high

1,673

52-week low

1,165.7

Revenue CAGR, 3 years (%)

7.37

Revenue CAGR, 5 years (%)

8.01

EPS CAGR, 3 years (%)

11.43

EPS CAGR, 5 years (%)

10

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

29.22%

FII

22.56%

DII

31.97%

Public

16.25%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• Lupin Ltd₹ 1,09,507.19 Cr
• Zydus Lifesciences Ltd₹ 1,17,705.45 Cr
• Mankind Pharma Ltd₹ 1,06,427 Cr
• Dr Reddy's Laboratories Ltd₹ 1,00,394.81 Cr
• Aurobindo Pharma Ltd₹ 92,831.47 Cr
• Laurus Labs Ltd₹ 86,501.22 Cr

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

• concall2026-07-27
• quarterly_result2026-07-23
• concall2026-07-04
• concall2026-07-03
• quarterly_result2026-05-13

Source: nse · as of 2026-10-05

Frequently asked questions

What does Cipla Ltd do?

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 26,615 full-time employees. The firm operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The firm's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The firm's geographical segments include India, the United States, South Africa, and Rest of the World. The firm has its network of manufacturing, trading and other incidental operations in India and International markets. The firm has approximately 47 manufacturing sites.

Which sector is Cipla Ltd in?

Cipla Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Cipla Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 28162.59 Cr, profit after tax 3879.23 Cr.

What is the promoter holding and pledge in Cipla Ltd?

Promoter holding is 29.22%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Cipla Ltd?

Companies in the same sector of similar size: Lupin Ltd, Zydus Lifesciences Ltd, Mankind Pharma Ltd, Dr Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Laurus Labs Ltd.